Abstract:Background: Acute stimulation of the late sodium current (I NaL ) as pharmacologically induced by Anemonia toxin II (ATX-II) results in Na + -dependent Ca 2+ overload and enhanced formation of reactive oxygen species (ROS). This is accompanied by an acute increase in the amplitude of the systolic Ca 2+ transient. Ca 2+ transient amplitude is determined by L-type Ca 2+ -mediated transsarcolemmal Ca 2+ influx (I Ca ) into the cytosol and by systolic Ca 2+ release from the sarcoplasmic reticulum (SR). Type-1 protein kinase A (PKARIα) becomes activated upon increased ROS and is capable of stimulating I Ca , thereby sustaining the amplitude of the systolic Ca 2+ transient upon oxidative stress. Objectives: We aimed to investigate whether the increase of the systolic Ca 2+ transient as acutely induced by I NaL (by ATX-II) may involve stimulation of I Ca through oxidized PKARIα. Methods: We used a transgenic mouse model in which PKARIα was made resistant to oxidative activation by homozygous knock-in replacement of redox-sensitive Cysteine 17 with Serine within the regulatory subunits of PKARIα (KI). ATX-II (at 1 nmol/L) was used to acutely enhance I NaL in freshly isolated ventricular myocytes from KI and wild-type (WT) control mice. Epifluorescence and confocal imaging were used to assess intracellular Ca 2+ handling and ROS formation. A ruptured-patch whole-cell voltage-clamp was used to measure I NaL and I Ca . The impact of acutely enhanced I NaL on RIα dimer formation and PKA target structures was studied using Western blot analysis. Results: ATX-II increased I NaL to a similar extent in KI and WT cells, which was associated with significant cytosolic and mitochondrial ROS formation in both genotypes. Acutely activated Ca 2+ handling in terms of increased Ca 2+ transient amplitudes and elevated SR Ca 2+ load was equally present in KI and WT cells. Likewise, cellular arrhythmias as approximated by non-triggered Ca 2+ elevations during Ca 2+ transient decay and by diastolic SR Ca 2+ -spark frequency occurred in a comparable manner in both genotypes. Most importantly and in contrast to our initial hypothesis, ATX-II did not alter the magnitude or inactivation kinetics of I Ca in neither WT nor KI cells and did not result in PKARIα dimerization (i.e., oxidation) despite a clear prooxidant intracellular environment. Conclusions: The inotropic and arrhythmogenic effects of acutely increased I NaL are associated with elevated ROS, but do not involve oxidation of PKARIα.

Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1s/sα2s/s Mouse Model of High Affinity for Cardiotonic Steroids

Thymoquinone Ameliorates Pressure Overload‐induced Cardiac Hypertrophy by Activating the AMPK Signalling Pathway

Sustained Oligomycin Sensitivity Conferring Protein Expression in Cardiomyocytes Protects Against Cardiac Hypertrophy Induced by Pressure Overload Via Improving Mitochondrial Function

STIM1 ablation impairs exercise-induced physiological cardiac hypertrophy and dysregulates autophagy in mouse hearts

Stimulation of Σ1-Receptor Restores Abnormal Mitochondrial Ca2 + Mobilization and ATP Production Following Cardiac Hypertrophy

Biased Effect of Cardiotonic Steroids on Na/K-ATPase–Mediated Signal Transduction

Reduction of Na/K-Atpase Potentiates Marinobufagenin-Induced Cardiac Dysfunction and Myocyte Apoptosis

Adaptation to exercise-induced stress is not dependent on cardiomyocyte α1A-adrenergic receptors

Myocardial Hypertrophy and Compensatory Increase in Systolic Function in a Mouse Model of Oxidative Stress

Abstract 12731: Acute Calcium/Calmodulin-Dependent Protein Kinase II Inhibition Augments Cardiomyocyte Contractility and Improves β-Adrenergic Regulation in Experimental Hypertension of Transgenic Rats Expressing Human Angiotensinogen Gene

The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2

Role of the Alkylglycerone Phosphate Synthase in Isoproterenol-Induced Cardiac Hypertrophy

Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy

[Oxidative Stress and Calcium/calmodulin-Dependent Protein Kinase II Contribute to the Development of Sustained Β Adrenergic Receptor-Stimulated Cardiac Hypertrophy in Rats].

Abstract 17040: Selective Inhibition of Myocardial NADPH Oxidase with a Dominant-Negative Mutant of P67 Phox Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Adult Transgenic Mice

Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development

Cd38 Promotes Angiotensin Ii-Induced Cardiac Hypertrophy

Abstract 13451: Upregulation of CaMKII and Contrast Changes of Cardiac β 1 - and β 3 -Adrenergic Signaling Pathways in a Humanized Angiotensinogen Model of Hypertension

Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.

Abstract P3054: Alpha-1a Adrenergic Receptor Activation Increases Electron Transport Chain Activity And Preserves Cardiac Contractility Following Myocardial Infarction

The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARIα